FDA
label_change
· 2023-12-15
FDA Approved: NALBUPHINE HYDROCHLORIDE — Supplemental Application (Hospira, Inc.)
Summary
FDA approved a supplemental application for nalbuphine hydrochloride by Hospira, updating labeling for this generic analgesic.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for NALBUPHINE HYDROCHLORIDE (NALBUPHINE HYDROCHLORIDE)